Ireland· IE-PA-PA1436/031/001
Modafinil Bluefish 100 mg tablets
A modafinil product containing modafinil, registered in Ireland by Bluefish Pharmaceuticals AB. The same ATC class is registered in 17 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Modafinil is registered in 17 of 19 countries.
Countries holding a registration under ATC N06BA07 (modafinil), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Modafinil · ATC N06BA07
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of modafinil costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $4.39 in France to $10.18 in Italy — a ×2.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Modafinil · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- IT Italy$10.18
- CH Switzerland$6.31
- FR France$4.39
The record
At a glance
HPRA (Ireland)- Active substance
- Modafinil
- Manufacturer
- Bluefish Pharmaceuticals AB
- Country
- Ireland (IE)
- ATC code
- N06BA07
- ATC class
- Modafinil
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1436/031/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
360 interactions on record for modafinil.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Modafinil · interactions on record
360 records
- 31 severe
- 128 moderate
- 103 minor
- 98 info
Most severe, free to view
- DeflazacortH02AB13severe
- BosutinibL01EA04severe
- EncorafenibL01EC03severe
- BrigatinibL01ED04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Modafinil in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesModafinilAlembic Pharmaceuticals Limited
- United KingdomModafinil 100mg tabletsA A H Pharmaceuticals Ltd
- CzechiaASPENDOSMedochemie Ltd., Limassol
- FranceMODAFINIL ARROW 100 mg, compriméARROW GENERIQUES
- SpainMODAFINILO ARISTO 100 MG COMPRIMIDOS EFGAristo Pharma Gmbh
- CanadaALERTECTEVA CANADA LIMITED
- SwedenModafinil Forza 100 mg TablettForza Advance Ltd.
- NetherlandsAspendos 100 mg, tablettenMedochemie Limited
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Modafinil Aristo, Modasomil
- Belgium · Provigil
- Bulgaria · Аспендос
- Cyprus · Aspendos, Modiodal
- Czechia · Aspendos, Vigil
- Germany · Modafinil Aristo, Modafinil Aurobindo
- Denmark · Modafinil, Modafinil Orifarm
- Spain · Modafinilo Aristo, Modafinilo Aurovitas
- Finland · Modafinil Orion
- France · Modafinil Arrow, Modafinil Biogaran
- United Kingdom (Northern Ireland) · Modafinil, Modafinil Dawa
- Greece · Aspendos
- Croatia · Vigifinil
- Iceland · Aspendos, Myldamo
- Italy · Provigil
- Luxembourg · Provigil
- Netherlands · Aspendos, Modafinil Aurobindo
- Norway · Modiodal
- Poland · Actimodan
- Portugal · Modafinil Forza, Modafinil Generis
- Romania · Aspendos
- Sweden · Modafinil Forza, Modafinil Orifarm
- Slovakia · Aspendos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7a56267c-e226-4593-a022-98f732fab464 GET /v1/drugs/7a56267c-e226-4593-a022-98f732fab464?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N06BA",
"N06BA07"
],
"strength": null,
"pa_number": "PA1436/031/001",
"substances": [
"Modafinil"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "12/06/2015",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": "IC0138-024-002"
}See everything about modafinil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.